Unmanaged Pharmacogenomic and Drug Interaction Risk Associations with Hospital Length of Stay among Medicare Advantage Members with COVID-19: A Retrospective Cohort Study

Unmanaged pharmacogenomic and drug interaction risk can lengthen hospitalization and may have influenced the severe health outcomes seen in some COVID-19 patients. To determine if unmanaged pharmacogenomic and drug interaction risks were associated with longer lengths of stay (LOS) among patients ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashcraft, Kristine, Moretz, Chad, Schenning, Chantelle, Rojahn, Susan, Vines Tanudtanud, Kae, Magoncia, Gwyn Omar, Reyes, Justine, Marquez, Bernardo, Guo, Yinglong, Erdemir, Elif Tokar, Hall, Taryn O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617857/
https://www.ncbi.nlm.nih.gov/pubmed/34834543
http://dx.doi.org/10.3390/jpm11111192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617857/
https://www.ncbi.nlm.nih.gov/pubmed/34834543
http://dx.doi.org/10.3390/jpm11111192

Ejemplares similares